COMMUNIQUÉS West-GlobeNewswire

TRU NIAGEN® to be featured at the American Society for Nutrition's Annual Meeting

29/05/2018 - 12:30

ChromaDex Chief Scientific Advisor, Charles Brenner, PhD, to discuss nicotinamide riboside in educational session IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science- [...]

Solon Eiendom ASA : Primary insider notification

29/05/2018 - 12:28

(Oslo, Norway, May 29, 2018) UFI AS has today bought 158 554 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]

Saniona reports positive results from Phase 1 study with new Tesomet tablet

29/05/2018 - 12:25

PRESS RELEASE May 29, 2018 Saniona, a leading biotech company within ion-channel research, today announced successful completion of the Phase 1 pharmacokinetic study for Saniona’s novel patented Tesomet tablet. The [...]

Solon Eiendom ASA : Primary insider notification

29/05/2018 - 12:23

(Oslo, Norway, May 29, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 100.000 shares and through his wholly owned company Skøien AS bought 270.485 [...]

Solon Eiendom ASA : Primary insider notification

29/05/2018 - 12:19

(Oslo, Norway, May 29, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 460,598 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. [...]

Quotient Limited Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Updates on CEO Appointment and MosaiQ™ European Field Trials

29/05/2018 - 12:15

MosaiQ European field trial which commenced on May 17, 2018 is ongoing Franz Walt is appointed as Chief Executive Officer Fourth quarter product revenues of $6.1 million, up 29.6% JERSEY, Channel Islands, May 29, 2018 ( [...]

PCI Biotech: Minutes from Annual General Meeting 2018

29/05/2018 - 12:07

Oslo, 29 May 2018. The Annual General Meeting in PCI Biotech Holding ASA took place today, 29 May 2018. All proposals in the call were approved. The Board of Directors consists of the following members until the next [...]

Emblem Corp. Reports 2018 First Quarter Results

29/05/2018 - 12:00

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 29, 2018 (GLOBE NEWSWIRE [...]

PotNetwork Holdings, Inc. Subsidiary Diamond CBD's Website Revenues in May Surpass Half a Million Dollars

29/05/2018 - 12:00

With Over a 1000% Gain Year Over Year, 2018 Sales Eclipse 2017, Internet Sales Reach $569,671 FT. LAUDERDALE, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holdings, Inc. (OTC Pink:POTN) is pleased to announce over [...]

Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer

29/05/2018 - 12:00

LOS ANGELES, May 29, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]

Quotient Limited appoints Franz Walt as Chief Executive Officer

29/05/2018 - 12:00

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executive Officer. Mr Walt [...]

ContraVir Pharmaceuticals to Present at 2018 BIO International Convention

29/05/2018 - 12:00

EDISON, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

CORRECT AND REPLACE: Wright Medical Group N.V. to Present at Jefferies Global Healthcare Conference

29/05/2018 - 12:00

Thursday, June 7, 2018 at 10:30 a.m. Eastern Time AMSTERDAM, The Netherlands, May 29, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI ) announced today that it will present at the Jefferies Global [...]

Mesoblast Partners With Cartherics to Develop ’off-the-shelf’ Cell-based Immunotherapies for Solid Cancers

29/05/2018 - 12:00

Relapsed Ovarian and Gastric Cancers Initial Targets for Allogeneic CAR-T Cells NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that it has [...]

BASF and Evogene announce multiyear collaboration for the development of novel insecticides

29/05/2018 - 12:00

The collaboration achieved its first milestone LUDWIGSHAFEN, Germany and REHOVOT, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- BASF, one of the world’s leading chemical companies, and Evogene Ltd. (NASDAQ: EVGN ) (TASE: [...]

Transactions in relation to share buyback program

29/05/2018 - 11:26

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

ViaDerma Announces Increase of Amazon Sales on the Heels of U.S. Department of Commerce Trade Mission to India

29/05/2018 - 11:00

LOS ANGELES, May 29, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is excited to report that since the inaugural sale of VitaStem on Amazon, January 2018, monthly sales continue to increase. In [...]

DBV Technologies Shows Commitment to the Development of Treatments for Food Allergies at EAACI 2018

29/05/2018 - 07:31

Montrouge, France, May 29, 2018 DBV Technologies Shows Commitment to the Development of Treatments for Food Allergies at EAACI 2018 Therapeutic potential of the Viaskin platform featured in seven abstracts Additional [...]

DBV Technologies poursuit son engagement pour le développement de traitements dans le domaine des allergies alimentaires à l'EAACI 2018

29/05/2018 - 07:31

Montrouge, France, le 29 mai (07h30 CEST) 2018 DBV Technologies poursuit son engagement pour le développement de traitements dans le domaine des allergies alimentaires à l'EAACI 2018 Le potentiel thérapeutique de la [...]